Expressing support for continued efforts to safeguard Medicare, Medicaid, and other Federal health care programs from fraud, waste, abuse, and improper payments through strengthened program integrity measures, enhanced oversight, and coordinated enforcement actions, and recognizing the work of the Trump administration and congressional Republicans to investigate and prosecute fraud and protect taxpayer dollars and preserve the long-term sustainability of the Nation's health care safety net.

On May 21, 2026, Rep. Finstad (R-MN) introduced H.Res. 1310, a House resolution expressing support for continued efforts to safeguard Medicare, Medicaid, and other federal health programs from fraud, waste, and abuse. The resolution was referred to the Energy and Commerce and Ways and Means Committees — early procedural stage. The resolution is purely expressive; it contains no authorized funding, no appropriation, no new enforcement authorities, and no changes to existing program integrity rules. The bill text cites GAO data on $100B+ in improper payments but does not mandate specific agency actions or budget increases. For investors, this is a legislative no-op. Resolution language does not bind CMS, HHS, or DOJ. It reinforces the existing enforcement status quo under the Trump administration but creates no incremental compliance costs, revenue risks, or contract opportunities for healthcare companies. Tickers like UNH, JNJ, and LLY face no measurable revenue or cost impact from this resolution. Their existing exposure to program integrity audits, prior authorization, and anti-fraud enforcement is unchanged. Pure-play fraud detection firms (no specific tickers identified in data) are not directly named.